---
title: "Institutional Research in the Past Week: Winner Medical Received the Most Institutional Inquiries"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246530840.md"
description: "In the past week, over 230 stocks underwent institutional research, with Winner Medical receiving the most attention from research institutions. The company stated that its consumer goods business performed well during the \"6.18\" promotion, benefiting from product innovation and precise marketing. Inovance also attracted the attention of more than a hundred institutions, with the average increase of researched stocks being 4.98%. Stocks such as Jingbeifang and Huasheng Lithium Battery saw increases of over 30%. The new lithium salt developed by Huasheng Lithium Battery is still in the testing phase, reminding investors to pay attention to risks"
datetime: "2025-06-29T05:00:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246530840.md)
  - [en](https://longbridge.com/en/news/246530840.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246530840.md)
generator: "portal-rs"
---

# Institutional Research in the Past Week: Winner Medical Received the Most Institutional Inquiries

In the past week, more than 230 stocks have been investigated by institutions, with Winner Medical receiving the most attention from research institutions. During the investigation, the company stated that its consumer goods business performed well during this year's "6.18" shopping festival, with significant improvements in key categories and channel development through product innovation, new product iterations, and targeted marketing. Inovance also received research from over a hundred institutions. From a market performance perspective, the average increase of stocks investigated by institutions in the past week was 4.98%. Stocks such as Jingbeifang and Huasheng Lithium Battery rose by more than 30%. During the investigation, Huasheng Lithium Battery stated that the dual trifluoromethyl sulfonimide lithium developed by the company is a new type of lithium salt that can be used as an additive for lithium-ion battery electrolytes and as an electrolyte for solid-state lithium batteries. Currently, the project is still in the small-scale trial production and sample testing stage and does not yet have the capacity for large-scale industrial production. Investors are advised to invest rationally and pay attention to investment risks

### Related Stocks

- [300888.CN](https://longbridge.com/en/quote/300888.CN.md)
- [300124.CN](https://longbridge.com/en/quote/300124.CN.md)
- [002987.CN](https://longbridge.com/en/quote/002987.CN.md)
- [688353.CN](https://longbridge.com/en/quote/688353.CN.md)
- [CP00043.US](https://longbridge.com/en/quote/CP00043.US.md)

## Related News & Research

- [Xtract One CEO Evans flags “vanity metrics” in weapons detection, urges focus on capture rates](https://longbridge.com/en/news/296946614.md)
- [Naturhouse Health chairman Felix Revuelta sells EUR 8,192 of shares](https://longbridge.com/en/news/296812947.md)
- [Seres-backed Aiva reportedly explores joining CATL battery swap network](https://longbridge.com/en/news/296920871.md)
- [07:45 ETFullspan Health Announces 2027 Marketing Solutions Built to Connect Brands With Consumers and Providers Across the Health Journey](https://longbridge.com/en/news/296908652.md)
- [Lithium Africa shareholders backed all items at annual meeting](https://longbridge.com/en/news/296777068.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**